ATC Group: J01DB05 Cefadroxil

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J01DB05 in the ATC hierarchy

Level Code Title
1 J Antiinfectives for systemic use
2 J01 Antibacterials for systemic use
3 J01D Other beta-lactam antibacterials
4 J01DB First-generation cephalosporins
5 J01DB05 Cefadroxil

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 2 g

Active ingredients in J01DB05

Active Ingredient Description
Cefadroxil

Cefadroxil is a cephalosporin for oral administration which inhibits bacterial wall synthesis of actively dividing cells by binding to one or more penicillin-binding proteins.

Related product monographs

Title Information Source Document Type  
AMBEN Capsule, hard Υπουργείο Υγείας (CY) MPI, EU: SmPC
AMBEN Powder for oral suspension Υπουργείο Υγείας (CY) MPI, EU: SmPC

Medicines in this ATC group

Austria (AT)

Brazil (BR)

Cyprus (CY)

Estonia (EE)

Germany (DE)

Hong Kong (HK)

Mexico (MX)

Nigeria (NG)

Poland (PL)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.